Nanoparticles for cancer therapy: current progress and challenges
S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
At present, nanoparticles are used for various biomedical applications where they facilitate
laboratory diagnostics and therapeutics. More specifically for drug delivery purposes, the …
laboratory diagnostics and therapeutics. More specifically for drug delivery purposes, the …
Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer
S Palanisamy, YM Wang - Dalton transactions, 2019 - pubs.rsc.org
Cancer is a global epidemic and is considered a leading cause of death. Various cancer
treatments such as chemotherapy, surgery, and radiotherapy are available for the cure but …
treatments such as chemotherapy, surgery, and radiotherapy are available for the cure but …
Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type
K Kettler, K Veltman, D van De Meent… - Environmental …, 2014 - Wiley Online Library
The increased application of nanoparticles (NPs) is increasing the risk of their release into
the environment. Although many toxicity studies have been conducted, the environmental …
the environment. Although many toxicity studies have been conducted, the environmental …
[HTML][HTML] Nanoparticles: Emerging carriers for drug delivery
SR Mudshinge, AB Deore, S Patil… - Saudi pharmaceutical …, 2011 - Elsevier
The core objective of nanoparticles is to control and manipulate biomacromolecular
constructs and supramolecular assemblies that are critical to living cells in order to improve …
constructs and supramolecular assemblies that are critical to living cells in order to improve …
Nanoparticles in cancer treatment: opportunities and obstacles
R Awasthi, A Roseblade, PM Hansbro… - Current drug …, 2018 - ingentaconnect.com
In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7
million. Historically, combination chemotherapy has been the primary choice of treatment …
million. Historically, combination chemotherapy has been the primary choice of treatment …
[PDF][PDF] RETRACTED ARTICLE: Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
Naqvi S, Samim M, Abdin M, et al. Int J Nanomedicine. 2010; 5: 983–989. The Editor and
Publisher of the International Journal of Nanomedicine wish to retract the published article …
Publisher of the International Journal of Nanomedicine wish to retract the published article …
Cancer theranostics: the rise of targeted magnetic nanoparticles
Interest in utilizing magnetic nanoparticles (MNP) for biomedical applications has increased
considerably over the past two decades. This excitement has been driven in large part by …
considerably over the past two decades. This excitement has been driven in large part by …
Magnetic nanoparticles: a novel platform for cancer theranostics
A Singh, SK Sahoo - Drug discovery today, 2014 - Elsevier
Highlights•MNPs act as theranostic agents because of intrinsic magnetic properties.•MNPs
act as a diagnostic tool by acting as contrast agents for MRI.•MNPs can deliver drugs or …
act as a diagnostic tool by acting as contrast agents for MRI.•MNPs can deliver drugs or …
Stabilization and functionalization of iron oxide nanoparticles for biomedical applications
Superparamagnetic iron oxide nanoparticles (NPs) are used in a rapidly expanding number
of research and practical applications in the biomedical field, including magnetic cell …
of research and practical applications in the biomedical field, including magnetic cell …